GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (OTCPK:DOSEF) » Definitions » 3-Year Revenue Growth Rate

DOSEF (Doseology Sciences) 3-Year Revenue Growth Rate : 0.00% (As of Mar. 2025)


View and export this data going back to 2022. Start your Free Trial

What is Doseology Sciences 3-Year Revenue Growth Rate?

Doseology Sciences's Revenue per Share for the three months ended in Mar. 2025 was $0.00.

During the past 12 months, Doseology Sciences's average Revenue per Share Growth Rate was -60.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Competitive Comparison of Doseology Sciences's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Doseology Sciences's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Doseology Sciences's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Doseology Sciences's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Doseology Sciences's 3-Year Revenue Growth Rate falls into.


;
;

Doseology Sciences 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Doseology Sciences  (OTCPK:DOSEF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Doseology Sciences 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Doseology Sciences Business Description

Traded in Other Exchanges
Address
9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.

Doseology Sciences Headlines

From GuruFocus

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-21-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-11-2022

Doseology Announces New Director and Corporate Secretary

By PRNewswire PRNewswire 05-05-2023

Doseology Announces CEO Transition

By PRNewswire PRNewswire 03-31-2023

Doseology Welcomes New CFO

By PRNewswire PRNewswire 03-03-2023

Doseology Uplists to OTCQB Market in USA

By PRNewswire PRNewswire 07-06-2022

Doseology Provides Corporate Update

By PRNewswire PRNewswire 01-23-2023

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-01-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-11-2022